EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits

Xiaolin Tian iD, Nathan Le, Yuhai Zhao, Dina Alawamleh, Andrew Schwartz, Lauren Meyer, Elizabeth Helm, Chunlai Wu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaolin Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Center of Excellence, Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA 70112, …. Hauptthemen laut MEDLINE: tau Proteins, Cognitive Dysfunction, Tauopathies. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH/NINDS, LIFT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using the fly eye as a model system, we previously demonstrated that upregulation of the fly gene mask protects against FUS- and Tau-induced photoreceptor degeneration. Building upon this finding, we investigated whether the protective role of mask is conserved in mammals. To this end, we generated a transgenic mouse line carrying Cre-inducible ANKHD1, the human homolog of mask. Utilizing the TauP301S-PS19 mouse model for Tau-related dementia, we found that expressing ANKHD1 driven by CamK2a-Cre reduced hyperphosphorylated human Tau in 6-month-old mice. Additionally, ANKHD1 expression was associated with a trend toward reduced gliosis and preservation of the presynaptic marker Synaptophysin, suggesting a protective role of ANKHD1 against TauP301S-linked neuropathology. At 9 months of age, novel object recognition (NOR) testing revealed cognitive impairment in female, but not male, PS19 mice. Notably, co-expression of ANKHD1 restored cognitive performance in the affected female mice. Together, this study highlights the novel effect of ANKHD1 in counteracting the adverse effects induced by the mutant human Tau protein. This finding underscores ANKHD1’s potential as a unique therapeutic target for tauopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsCognitive DysfunctionTauopathiesAnimalsPhosphorylationMiceMice, TransgenicFemaleMaleHumansDisease Models, AnimalUp-Regulation

Stichwörter der Autor:innen

ANKHD1PS19 mouseTau phosphorylationcognitive deficits

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Neuroscience Center of Excellence, Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
  • Louisiana State University Health Sciences Center, School of Medicine, New Orleans, LA 70112, USA.
  • LSU Health Shreveport, School of Medicine, 1501 Kings Highway, Shreveport, LA 71103, USA.

ORCID-Profile: Xiaolin Tian, Chunlai Wu

Förderung

  • NINDS NIH HHS
  • NIH/NINDS
  • LIFT

Zitieren

APA

Tian, X., Le, N., Zhao, Y., Alawamleh, D., Schwartz, A., Meyer, L., Helm, E., & Wu, C. (2025). Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157524

Vancouver

Tian X, Le N, Zhao Y, Alawamleh D, Schwartz A, Meyer L, et al. Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157524

BibTeX
@article{Tian2025,
  author = {Tian, Xiaolin and Le, Nathan and Zhao, Yuhai and Alawamleh, Dina and Schwartz, Andrew and Meyer, Lauren and Helm, Elizabeth and Wu, Chunlai},
  title = {Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157524}
}
Kostenlos starten →